ULIXE CORP. (ULIX) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 8, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-K for Q3 FY2025, filed Jun 23, 2025. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the ULIX SEC filings page.
This page shows ULIXE CORP. (ULIX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
ULIXE CORP. does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
ULIXE CORP. passes 1 of 5 computable financial strength tests (4 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).
ULIXE CORP. reported a net loss of $129K while operations used $83K of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
None of these metrics is reported for Q3 2025.
Cash & Balance Sheet
ULIXE CORP. held $8 in cash as of Q3 2025; long-term debt is not reported for that period.
Not reported for Q3 2025.
Not reported for Q3 2025.
Margins & Returns
None of these metrics is reported for Q3 2025.
Capital Allocation
None of these metrics is reported for Q3 2025.
ULIX Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, EPS (Diluted), Diluted Shares (Avg).
ULIX Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2510-K | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $257K+6.4% | $251K+6.6% | $244K+10.0% | $237K+10.3% | $242K+12.6% | $235K+13.2% | $222K+7.4% | $215K-37.9% |
| Current Assets | $15K-0.1% | $15K-0.1% | $15K+0.1% | $15K+0.2% | $15K+0.1% | $15K-1.9% | $15K-3.3% | $15K-46.5% |
| Cash & Equivalents | $8-66.7% | $8-50.0% | $19+216.7% | $39+143.8% | $24+700.0% | $16-94.8% | $6-98.8% | $16-99.9% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $122K+62.5% | $111K+69.8% | $100K+113.2% | $81K+132.5% | $75K+132.0% | $65K+250.5% | $47K+604.4% | $35K-74.8% |
| Current Liabilities | $122K+62.5% | $111K+69.8% | $100K+113.2% | $81K+132.5% | $75K+132.0% | $65K+250.5% | $47K+604.4% | $35K-74.8% |
| Non-Current Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Equity | $136K-18.8% | $140K-17.8% | $144K-17.7% | $156K-13.4% | $167K-8.6% | $170K-10.2% | $175K-12.5% | $180K-13.2% |
| Retained Earnings | -$636K-27.3% | -$632K-27.2% | -$628K-27.6% | -$616K-26.5% | -$500K-3.2% | -$497K-2.6% | -$492K-20.0% | -$487K-21.0% |
Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill, Long-Term Debt.
ULIX Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2510-K | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $7K-0.1% | $7K-50.1% | $7K-0.1% | -$110K-844853.8% | $7K+113.6% | $14K+886.1% | $7K+104.8% | $13-99.7% |
| Investing Cash Flow | -$7K0.0% | -$7K+50.0% | -$7K0.0% | $5K | -$7K+10.0% | -$13K-752.7% | -$7K-105.3% | $0+100.0% |
| Financing Cash Flow | $0 | $0 | $0 | $105K | $0 | $0 | $0 | $0 |
Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.
ULIX Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2510-K | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K |
|---|---|---|---|---|---|---|---|---|
| Return on Equity | N/A | N/A | -8.4%-5.4pp | N/A | N/A | -2.9%+2.7pp | -3.0%+0.9pp | N/A |
| Return on Assets | N/A | N/A | -5.0%-2.6pp | N/A | N/A | -2.1%+3.0pp | -2.4%+1.4pp | N/A |
| Current Ratio | 0.12-0.1x | 0.14-0.1x | 0.15-0.2x | 0.19-0.2x | 0.20-0.3x | 0.23-0.6x | 0.32-2.0x | 0.43+0.2x |
| Debt-to-Equity | 0.90+0.4x | 0.79+0.4x | 0.70+0.4x | 0.52+0.3x | 0.45+0.3x | 0.38+0.3x | 0.27+0.2x | 0.19-0.5x |
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Asset Turnover, FCF Margin.
Note: The current ratio is below 1.0 (0.19), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Where ULIXE CORP. Ranks
Frequently Asked Questions
Is ULIXE CORP. profitable?
No, ULIXE CORP. (ULIX) reported a net income of -$129K in fiscal year 2024.
What is ULIXE CORP.'s return on equity (ROE)?
ULIXE CORP. (ULIX) has a return on equity of -82.8% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.
What is ULIXE CORP.'s operating cash flow?
ULIXE CORP. (ULIX) recorded an outflow of $83K in operating cash flow during fiscal year 2024, representing cash used by core business activities.
What are ULIXE CORP.'s total assets?
ULIXE CORP. (ULIX) had $237K in total assets as of fiscal year 2024, including both current and long-term assets.
What is ULIXE CORP.'s current ratio?
ULIXE CORP. (ULIX) had a current ratio of 0.19 as of fiscal year 2024, which is below 1.0, which may suggest potential liquidity concerns.
What is ULIXE CORP.'s debt-to-equity ratio?
ULIXE CORP. (ULIX) had a debt-to-equity ratio of 0.52 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is ULIXE CORP.'s return on assets (ROA)?
ULIXE CORP. (ULIX) had a return on assets of -54.4% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
What is ULIXE CORP.'s P/E ratio?
ULIXE CORP. (ULIX) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2024). The market capitalization is $1.5M as of Sep 8, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is ULIXE CORP.'s price-to-sales ratio?
ULIXE CORP. (ULIX) has no price-to-sales ratio at the moment: no revenue reported. The market capitalization is $1.5M as of Sep 8, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
How does ULIXE CORP.'s liquidity compare with its operating cash outflow?
At the end of fiscal year 2024, ULIXE CORP. (ULIX) held $39 in cash, cash equivalents and investments, and reported an operating cash outflow of $83K over that year. Dividing the one by the other, the reported balance equals about 0 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
What is ULIXE CORP.'s Piotroski F-Score?
ULIXE CORP. (ULIX) has a Piotroski F-Score of 1 out of 5 computable signals; 4 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are ULIXE CORP.'s earnings high quality?
ULIXE CORP. (ULIX) reported a net loss of $129K while operations used $83K of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.